The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2506834
WO Application Number:
IB2010003394
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP10812803.4
WO Publication Number:
WO2011067673
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:
Dates
Filing date:
03/12/2010
Grant date:
02/03/2016
EP Publication Date:
10/10/2012
WO Publication Date:
09/06/2011
Claims Translations Received Date:
Claims Translation B1 Received Date:
31/03/2016
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
02/03/2016
EP B1 Publication Date:
02/03/2016
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
02/12/2030
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
17/07/2025
Name:
Seqirus UK Limited
Address:
Point, 29 Market Street
Berkshire, SL6 8AA, Maidenhead, United Kingdom (GB)
Historical Applicant/holder
From:
02/03/2016
To:
17/07/2025
Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, BASEL, Switzerland (CH)
Agent
Name:
dr. R.C. van Duijvenbode c.s.
From:
12/06/2025
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)